Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
3.320
+0.020 (0.61%)
Oct 31, 2025, 12:18 PM EDT - Market open
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $1.86 million as of October 31, 2025. Its market cap has decreased by -26.20% in one year.
Market Cap
1.86M
Enterprise Value
5.16M
1-Year Change
-26.20%
Ranking
Category
Stock Price
$3.32
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $1.86M, a decrease of -98.75%. That is a compound annual growth rate of -61.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 1.85M | -42.55% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | 148.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.14B |
| Johnson & Johnson | 455.48B |
| AbbVie | 403.13B |
| UnitedHealth Group | 312.23B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 216.98B |